Healthcare entity
All 1 tracked stories fall under one category: market-trends. Bilal Cassim is most often covered alongside Royal Australian and New Zealand College of Psychiatrists (RANZCP), which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.3 in the same window.
Last mentioned: Mar 20, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. Bilal Cassim is most often covered alongside Royal Australian and New Zealand College of Psychiatrists (RANZCP), which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Each story carries 2 original sources on average, compared with 2.9 for the broader beat in this window. Bilal Cassim appears in 1 tracked Healthcare story from March 20, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bilal Cassim. Shared-story counts are live from our verified record — not editorial picks.
The public endorsement of medicinal cannabis by patients like Bilal Cassim for PTSD and insomnia highlights a significant shift in Australian healthcare toward cannabinoid therapies. This trend reflects a broader move toward alternative mental health treatments as the clinical and regulatory landscape continues to evolve.
Bilal Cassim is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
